Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice

American Journal of Pathology

Volumn 159, Issue 6, 2001, Pages 2227-2237

  Teesalu, Tambet ^a   Hinkkanen, Ari E ^b   Vaheri, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GELATINASE B; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE; PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VITRONECTIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOREACTIVITY; INFLAMMATORY CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; WHITE MATTER; ZYMOGRAPHY;

EID: 0035184313     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63073-8     Document Type: Article

References (70)

1. ECM and cell surface proteolysis: Regulating cellular ecology
2. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development
3. Proteolytic remodeling of extracellular matrix
4. The urokinase-type plasminogen activator in cancer metastasis: A review
5. Control of matrix metalloproteinase activity in cancer
6. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator
7. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation
8. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes
9. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases
10. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein
11. The expression of tissue type plasminogen activator, matrix metalloproteinases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution
12. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
13. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteinases
14. Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine
15. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790
16. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumor necrosis factor-alpha inhibitor
17. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis
18. Tissue plasminogen activator gene expression in multiple sclerosis brain tissue
19. Plasma and cerebrospinal fluid activities of tissue plasminogen activator, urokinase and PAI-1 in multiple sclerosis
20. Physical state of the neuroantigen in adjuvant emulsion determines encephalogenic status in the Balb/C mouse
21. 2MR/LRP genes
22. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney
23. Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator
24. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1
25. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract
26. Molecular cloning and sequencing of the murine alpha-2-macroglobulin receptor cDNA
27. Distinct expression of gelatinase A (MMP-2), collagenase-3 (MMP-13), membrane type MMP (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological ligands during formation and regression of the rat corpus luteum
28. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation
29. Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase
30. Expression of the protooncogene int-1 is restricted to specific neural cells in the developing mouse embryo
31. Physiological consequences of loss of plasminogen activator gene function in mice
32. Metalloproteases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths
33. Neutrophils secreting tumor necrosis factor alpha infiltrate the CNS of Balb/c mice with EAE
34. Physical state of the antigen/adjuvant emulsion determines encephalogenicity in Balb/c mice
35. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein
36. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons
37. Amiloride selectively inhibits the urokinase-type plasminogen activator
38. Expression of matrix metalloproteinases during murine chorioallantoic placenta formation
39. Subcellular localization and release of human neutrophil gelatinase confirming the existence of separate gelatinase-containing granules
40. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis
41. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
42. The localization of fibrin, fibronectin and class II major histocompatibility complex antigen in the spinal cord in chronic relapsing experimental allergic encephalomyelitis
43. The immunopathology of acute experimental allergic encephalomyelitis. A light microscopic and ultrastructural immunohistochemical analysis of fibronectin and fibrinogen
44. Fibrin deposition in the central nervous system correlates with the degree of Theiler's murine encephalomyelitis virus-induced demyelinating disease
45. Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
46. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system
47. Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning
48. Tissue plasminogen activator and neuronal cell death
49. Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene
50. The plasmin system is induced by and degrades amyloid-beta aggregates
51. The plasminogen-plasmin system in malignancy
52. Evidence of persistent blood-brain barrier abnormalities in chronic progressive multiple sclerosis
53. Role of the clotting system in the pathogenesis of neuroimmunologic disease
54. Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumor necrosis factoralpha and nitrite release
55. Fibrin enhances the expression of II-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation
56. Structure and function of human tissue-type plasminogen activator
57. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury
58. Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats
59. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin
60. Targeted gene manipulation and transfer of the plasminogen and coagulation systems in mice
61. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
62. Characterization of the activation of latent TGF-beta by co-cultures of pericytes and smooth muscle cells: A self-regulating system
63. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
64. Antagonistic effects endogenous and exogenous TGF-β and TNF on autoimmune diseases in mice
65. Role of astrocyte-derived tissue-type plasminogen activator in the regulation of endotoxin-stimulated nitric oxide production by microglial cells
66. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
67. Regulation of plasminogen activator inhibitor-1 mRNA accumulation by basic fibroblast growth factor and transforming growth factor-beta in cultured rat astrocytes
68. A matrix metalloproteinase expressed on the cell surface of invasive tumor cells
69. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3
70. 2-terminal sequences of late-stage digest fragments